Cutler Group LLC / CA - ACLARIS THERAPEUTICS INC ownership

ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 145 filers reported holding ACLARIS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.3%.

Quarter-by-quarter ownership
Cutler Group LLC / CA ownership history of ACLARIS THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$10,000
-89.2%
600
-93.3%
0.00%
-100.0%
Q1 2021$93,000
+304.3%
8,900
+117.1%
0.01%
+400.0%
Q4 2020$23,000
+155.6%
4,1000.0%0.00%0.0%
Q3 2020$9,000
+80.0%
4,100
+20.6%
0.00%
Q2 2020$5,000
+66.7%
3,400
-22.7%
0.00%
Q1 2020$3,000
-50.0%
4,400
-10.2%
0.00%
Q4 2019$6,000
-84.6%
4,900
-67.3%
0.00%
-100.0%
Q3 2019$39,000
-20.4%
15,000
-20.6%
0.00%
-20.0%
Q2 2019$49,000
+1125.0%
18,900
+721.7%
0.01%
Q1 2019$4,000
-55.6%
2,300
+64.3%
0.00%
-100.0%
Q4 2018$9,000
+200.0%
1,400
+600.0%
0.00%
Q2 2018$3,000
-62.5%
200
-60.0%
0.00%
-100.0%
Q1 2018$8,000
-57.9%
500
-37.5%
0.00%0.0%
Q4 2017$19,000
+850.0%
800
+700.0%
0.00%
Q3 2017$2,000
-50.0%
100
-97.4%
0.00%
Q2 2017$4,000
-76.5%
3,9000.0%0.00%
-100.0%
Q1 2017$17,0003,900
+200.0%
0.00%
Q4 2016$01,3000.00%
Other shareholders
ACLARIS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 441,000$833,0002.78%
MFN Partners Management, LP 4,000,000$7,560,0001.56%
Endurant Capital Management LP 2,055,069$3,884,0001.22%
Broadfin Capital, LLC 1,888,039$3,568,0000.48%
Aisling Capital Management LP 634,455$1,199,0000.46%
EcoR1 Capital, LLC 2,087,312$3,945,0000.36%
Sofinnova Investments, Inc. 1,911,573$3,613,0000.26%
Alambic Investment Management, L.P. 115,036$217,0000.18%
Parkman Healthcare Partners LLC 225,000$425,0000.12%
Rock Springs Capital Management LP 1,600,000$3,024,0000.10%
View complete list of ACLARIS THERAPEUTICS INC shareholders